Alexandra Balcom

Companies

• CRESCENT BIOPHARMA, INC.Board member Jun 23, 2025 to now¹
• Nuvalent, Inc.Chief financial officer Jul 28, 2021 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NNuvalent, Inc.0 shares³Jul 15, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 15, 2026Returned to company 14,350 shares of Nuvalent, Inc.³
• Jul 15, 2026Granted 14,350 shares of Nuvalent, Inc.³
• Jul 15, 2026Returned to company 41,100 shares of Nuvalent, Inc.³
• Jul 15, 2026U 44,433 shares at $124.00 of Nuvalent, Inc.³
• Jul 1, 2026Sold 11,430 shares at $123.58 of Nuvalent, Inc.⁴
• Jul 1, 2026Exercised options 6,046 shares at $18.93 of Nuvalent, Inc.⁴
• Jul 1, 2026Exercised options 5,384 shares at $6.89 of Nuvalent, Inc.⁴
• Jun 1, 2026Sold 200 shares at $103.84 of Nuvalent, Inc.⁵
• Jun 1, 2026Sold 279 shares at $101.79 of Nuvalent, Inc.⁵
• Jun 1, 2026Sold 2,588 shares at $100.65 of Nuvalent, Inc.⁵
• Jun 1, 2026Sold 3,133 shares at $99.86 of Nuvalent, Inc.⁵
• Jun 1, 2026Sold 1,200 shares at $98.57 of Nuvalent, Inc.⁵
• Jun 1, 2026Sold 900 shares at $97.68 of Nuvalent, Inc.⁵
• Jun 1, 2026Sold 2,170 shares at $95.99 of Nuvalent, Inc.⁵
• Jun 1, 2026Sold 960 shares at $94.87 of Nuvalent, Inc.⁵
• Jun 1, 2026Exercised options 11,430 shares at $6.89 of Nuvalent, Inc.⁵
• May 1, 2026Sold 124 shares at $99.97 of Nuvalent, Inc.⁶
• May 1, 2026Sold 7,434 shares at $99.29 of Nuvalent, Inc.⁶
• May 1, 2026Sold 3,872 shares at $98.42 of Nuvalent, Inc.⁶
• May 1, 2026Exercised options 4,271 shares at $6.89 of Nuvalent, Inc.⁶
• May 1, 2026Exercised options 7,159 shares at $1.08 of Nuvalent, Inc.⁶
• Apr 1, 2026Sold 2,469 shares at $106.18 of Nuvalent, Inc.⁷
• Apr 1, 2026Sold 5,417 shares at $105.30 of Nuvalent, Inc.⁷
• Apr 1, 2026Sold 3,544 shares at $104.39 of Nuvalent, Inc.⁷
• Apr 1, 2026Exercised options 11,430 shares at $1.08 of Nuvalent, Inc.⁷